BioCentury
ARTICLE | Financial News

Ambit sets IPO range

May 3, 2013 12:23 AM UTC

Ambit Biosciences Corp. (San Diego, Calif.) amended its IPO and now plans to sell 4.6 million shares at $13-15. At the $14 mid-point, Ambit would raise $65 million and be valued at $180.4 million. Citigroup; Leerink; BMO Capital Markets; and Baird are underwriters. Ambit proposed to raise up to $57.5 million in an IPO in February. ...